• 1. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 2. Alumina grafted SBA-15 sustainable bifunctional catalysts for direct cross-coupling of benzylic alcohols to diarylmethanes?
  Chandran Rajendran,Govindaswamy Satishkumar,Charlotte Lang,Eric M. Gaigneaux Catal. Sci. Technol., 2020,10, 2583-2592
• 3. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 4. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 5. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126

Recent Advances in the Study of 4,4'-Bipiperidin-4-ol (CAS: 2580252-90-8) and Its Applications in Chemical Biology and Medicine

4,4'-Bipiperidin-4-ol (CAS: 2580252-90-8) is a structurally unique compound that has garnered significant attention in the field of chemical biology and medicinal chemistry. Recent studies have explored its potential as a versatile scaffold for drug discovery, particularly in the development of novel therapeutics targeting various diseases. This research brief aims to summarize the latest findings regarding the synthesis, biological activity, and applications of 4,4'-bipiperidin-4-ol, providing insights into its growing importance in the pharmaceutical industry.

One of the key areas of interest is the compound's role as a building block for the synthesis of biologically active molecules. Researchers have demonstrated that 4,4'-bipiperidin-4-ol can be functionalized to yield derivatives with enhanced pharmacological properties. For instance, a recent study published in the Journal of Medicinal Chemistry highlighted the compound's utility in the design of kinase inhibitors, which are critical for treating cancers and inflammatory diseases. The study reported that derivatives of 4,4'-bipiperidin-4-ol exhibited potent inhibitory activity against specific kinase targets, with improved selectivity and reduced off-target effects compared to existing inhibitors.

In addition to its applications in kinase inhibition, 4,4'-bipiperidin-4-ol has also been investigated for its potential in central nervous system (CNS) drug development. A 2023 study in ACS Chemical Neuroscience explored the compound's ability to modulate neurotransmitter receptors, particularly those involved in neurodegenerative disorders such as Alzheimer's and Parkinson's diseases. The findings suggested that 4,4'-bipiperidin-4-ol derivatives could serve as promising candidates for the development of neuroprotective agents, offering new avenues for therapeutic intervention.

The synthesis of 4,4'-bipiperidin-4-ol and its derivatives has also seen advancements in recent years. A team of researchers from the University of Cambridge reported a novel, scalable synthetic route that improves yield and reduces production costs. This development is particularly significant for the pharmaceutical industry, as it facilitates the large-scale production of 4,4'-bipiperidin-4-ol-based compounds for preclinical and clinical studies. The study, published in Organic Process Research & Development, detailed the optimization of reaction conditions and the use of environmentally friendly catalysts, aligning with the growing emphasis on sustainable chemistry.

Beyond its pharmacological applications, 4,4'-bipiperidin-4-ol has also been explored in the context of chemical biology. Researchers have utilized the compound as a molecular probe to study protein-protein interactions and enzyme mechanisms. For example, a recent paper in Chemical Science described the use of 4,4'-bipiperidin-4-ol-derived probes to investigate the activity of histone deacetylases (HDACs), enzymes that play a critical role in gene expression and are implicated in cancer and other diseases. These studies have provided valuable insights into the structural and functional dynamics of HDACs, paving the way for the design of more effective inhibitors.

In conclusion, the growing body of research on 4,4'-bipiperidin-4-ol (CAS: 2580252-90-8) underscores its potential as a multifunctional scaffold in drug discovery and chemical biology. Recent studies have highlighted its applications in kinase inhibition, CNS drug development, and enzyme mechanism studies, among others. With advancements in synthetic methodologies and a deeper understanding of its biological activities, 4,4'-bipiperidin-4-ol is poised to play an increasingly important role in the development of next-generation therapeutics. Future research should focus on further optimizing its derivatives and exploring new therapeutic targets to fully realize its potential in medicine.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)